News

Evaluation results – ERC Proof of Concept grant 2022 2 call – 2nd cut-off 19 May 2022

Published on | 3 years ago

Programmes
ERC

Principal Investigators with a European Research Council grant that is running or ended less than 12 months before 1 January of the call year are eligible to participate in an ERC Proof of Concept Grant. The ERC Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to PIs whose proposals draw substantially on their ERC funded research. The results of the 2022 Proof of Concept 2 call (2nd cut-off 19 May 2022) were published. In total 55 ERC grant holders received a Proof of Concept grant including one researcher based at a Flemish host institution:

  • Mohamed Lamkanfi, Universiteit Gent, “PyroScreen - Targeting NLRP3-mediated inflammation with novel chemotypes” which builds on the research funded by the 2015 Consolidator grant “PyroPOP - Mechanisms and regulation of inflammasome-associated programmed cell death”

More information on the PyroScreen project and the PoC call results can be found in the press releases of Universiteit Gent and ERCEA 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1851 articles available search in articles 

Testimonial

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.